t 588 has been researched along with Cranial Nerve VII Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, K; Iwasaki, Y; Kawazoe, Y; Kinoshita, M; Marubuchi, S; Nakagawa, M; Ono, S; Sakamoto, T; Terashima, N; Watabe, K | 1 |
Hayashi, Y; Kawazoe, Y; Watabe, K | 1 |
2 other study(ies) available for t 588 and Cranial Nerve VII Injuries
Article | Year |
---|---|
Oral administration of a neuroprotective compound T-588 prevents motoneuron degeneration after facial nerve avulsion in adult rats.
Topics: Administration, Oral; Age Factors; Animals; Body Weight; Cell Survival; Choline O-Acetyltransferase; Diethylamines; Facial Nerve Injuries; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lectins; Male; Motor Neuron Disease; Motor Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; Thiophenes | 2003 |
Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration.
Topics: Adenoviridae; Animals; Brain-Derived Neurotrophic Factor; Diethylamines; Disease Models, Animal; Facial Nerve Injuries; Gene Transfer Techniques; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Male; Metallothionein 3; Motor Neuron Disease; Motor Neurons; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Peripheral Nerve Injuries; Peripheral Nerves; Rats; Thiophenes; Transforming Growth Factor beta | 2005 |